Nexilico

About:

Nexilico is an early-stage startup developing predictive computational platforms for gut microbiome precision medicine.

Top Investors: National Science Foundation, National Institutes of Health, SkyDeck Berkeley, CITRIS Foundry

Description:

Nexilico, Inc. is an early-stage startup with the mission to advance microbiome and precision medicine research and development by developing next generation of predictive, computational platforms that improve drug design and development as well as therapeutics clinical outcome.

Total Funding Amount:

$2.05M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2019-01-01

Founders:

Mohammad Mofrad, Mohammad Soheilypour

Number of Employees:

1-10

Last Funding Date:

2023-09-01

IPO Status:

Private

Industries: